Long Noncoding RNAs: Clarity or Confusion?
Because They Are Such Elusive Prey, lncRNAs Have Yet to Emerge as Therapeutic Targets
Markets Expand for Single-Use Bioreactors
Biobags Offer Advantages Over Fixed-Tank Systems
The Challenges of Harmonizing Biomarker Data
Why Trial Success Depends on It
Top 10 Wall Street Losers of 2016
These Companies Lost the Most in a Down Year for Biopharma Stocks
Alan Russell (Ph.D. in Biological Chemistry, 1987, Imperial College of Science and Technology, University of London) is the Highmark Distinguished Professor in the Institute for Complex and Engineered Systems at Carnegie Mellon University. He is also the executive director of the Pittsburgh Tissue Engineering Initiative and the director of the National Tissue Engineering Center.
Dr. Russell was the founding director of the McGowan Institute for Regenerative Medicine, jointly established by the University of Pittsburgh School of Medicine and UPMC Health System as a center of expertise and education in therapies that reestablish tissue and organ function. The McGowan Institute is a center for research and clinical work in tissue engineering, adult-derived stem cell research and cellular therapies, biosurgery, and artificial and biohybrid organ devices. He was also founding president of the 3,000-member Tissue Engineering and Regenerative Medicine International Society.
He has given more than 250 national and international invited lectures. He holds 14 patents and has 23 patents pending.
More GEN Content From This Contributor:
- Biopharmaceutical: Alan J. Russell, Ph.D.
- Biopharmaceutical: <i>Disruptive Science and Technology</i>: A New Journal
- Columns: Disrupting Alzheimer’s Disease Research